SCHEMBL980652

SCHEMBL980652

O=C(c1ccccc1)c1ccc2ccccc2c1C(=O)c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.53
LDHA P00338 1/20 0.52
AKR1C3 P42330 1/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
NR4A1 P22736 1/20 0.47
NR4A2 P43354 1/20 0.47
NR4A3 Q92570 1/20 0.47
GLA P06280 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GAA P10253 2/20 0.46
CDC25B P30305 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31304979 1.00 WDR5 (0.53) WDR5LDHAAKR1C3ALDH1A1MEN1
SCHEMBL1666411 0.91 WDR5 (0.49) WDR5LDHAAKR1C3ALDH1A1MEN1
SCHEMBL27716376 0.91 WDR5 (0.49) WDR5LDHAAKR1C3ALDH1A1MEN1
SCHEMBL28375053 0.91 WDR5 (0.49) WDR5LDHAAKR1C3ALDH1A1MEN1
SCHEMBL12486587 0.91 WDR5 (0.61) WDR5LDHAAKR1C3ALDH1A1MEN1
SCHEMBL21815755 0.90 WDR5 (0.47) WDR5LDHAAKR1C3ALDH1A1MEN1
SCHEMBL425867 0.87 ALDH1A1 (0.49) WDR5LDHAALDH1A1MEN1KMT2A
SCHEMBL8418472 0.86 CYP1B1 (0.50) WDR5LDHAMEN1KMT2AKDM4E
SCHEMBL1666525 0.84 KDM4E (0.47) AKR1C3ALDH1A1MEN1KMT2AKDM4E
SCHEMBL9807419 0.83 LDHA (0.70) WDR5LDHAMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118580178-A Method for synthesizing C-4 alkylpyridine by taking alcohol as alkylating reagent 陕西师范大学 2024-09-03 CN claimed
JP-6234848-A None JP disclosed
CN-118580178-A Method for synthesizing C-4 alkylpyridine by taking alcohol as alkylating reagent 陕西师范大学 2024-09-03 CN disclosed
CN-112218844-B Compound, resin, composition, resist pattern forming method, circuit pattern forming method, and resin purifying method 三菱瓦斯化学株式会社 2024-04-26 CN disclosed
US-20240109997-A1 RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, CIRCUIT PATTERN FORMATION METHOD AND METHOD FOR PURIFYING RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-04-04 US disclosed
US-20230333469-A1 FILM FORMING COMPOSITION FOR LITHOGRAPHY, RESIST PATTERN FORMATION METHOD, AND CIRCUIT PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-10-19 US disclosed
CN-116888181-A Resin, composition, resist pattern forming method, circuit pattern forming method, and resin purifying method 三菱瓦斯化学株式会社 2023-10-13 CN disclosed
CN-111655662-B Compound, resin, composition, resist pattern forming method, circuit pattern forming method, and resin purifying method 三菱瓦斯化学株式会社 2023-09-26 CN disclosed
US-11747728-B2 Compound, resin, composition, resist pattern formation method, circuit pattern formation method and method for purifying resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-09-05 US disclosed
CN-115836045-A Composition for forming photoresist, method for forming resist pattern, and method for forming circuit pattern 三菱瓦斯化学株式会社 2023-03-21 CN disclosed
CN-1606540-A Synthesis and use of dimethyl 1,5-naphthalenedicarboxylates and intermediates therefrom BP CORP NORTH AMERICA INC (US) 2005-04-13 CN disclosed
EP-1368297-A2 SYNTHESIS AND USE OF DIMETHYL-1,5-NAPHTHALENEDICARBOXYLATES AND INTERMEDIATES THEREFROM BP Corporation North America Inc. (US) 2003-12-10 EP disclosed
US-6495710-B2 Synthesis and use of dimethyl 1,5-naphthalenedicarboxlyates and intermediates therefrom BP CORPORATION NORTH AMERICA INC. 2002-12-17 US disclosed
US-20010031852-A1 Synthesis and use of dimethyl 1,5-naphthalenedicarboxylates and intermediates therefrom BP CORPORATION NORTH AMERICA INC. 2001-10-18 US disclosed
WO-2001051450-A2 SYNTHESIS AND USE OF DIMETHYL-1,5-NAPHTHALENEDICARBOXYLATES AND INTERMEDIATES THEREFROM BP CORPORATION NORTH AMERICA INC. (US) 2001-07-19 WO disclosed
JP-H06234848-A NEW DIBENZOYLNAPHTHALENE DERIVATIVE, POLYMER CONTAINING THE SAME DERIVATIVE AND ITS PRODUCTION JAPAN ENERGY CORP 1994-08-23 JP disclosed
EP-0391268-B1 Manufacture of dyestuffs of the dibenzopyrenequinone series HOECHST AG (DE) 1994-02-09 EP disclosed
US-5126427-A For stable solutions in halogenated hydrocarbons, solvent resistance, thermal poroperties, molding materials, coatings CIBA-GEIGY CORPORATION (US) 1992-06-30 US disclosed
EP-0391268-A1 Manufacture of dyestuffs of the dibenzopyrenequinone series HOECHST AKTIENGESELLSCHAFT (DE) 1990-10-10 EP disclosed
EP-0391268-A1 Manufacture of dyestuffs of the dibenzopyrenequinone series HOECHST AKTIENGESELLSCHAFT (DE) 1990-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11747728-B2 Compound, resin, composition, resist pattern formation method, circuit pattern formation method and method for purifying resin RER1, FEM1B, UNC119 WDR5 393/4885LDHA 4223/4885AKR1C3 2524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.